Newsfeeds Archive - Page 2 of 15

3 minute read

Crude Oil Rises Over 1%; DuPont Shares Plunge

January 24, 1:04 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The S&P 500 also rose, gaining, 0.66% to 4,896.89.

ANVS

1 minute read

Why SciSparc Stock Is Lighting Up

By Erica Kollmann

January 24, 11:54 AM

SciSparc Ltd. shares are trading higher Wednesday after the company announced that it has entered into a standby equity purchase agreement with YA II PN, Ltd., a fund managed by Yorkville Advisors Global, LP.

SPRC

3 minute read

Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales

By Avi Kapoor

January 24, 10:43 AM

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.29% to 38,013.76 while the NASDAQ rose 0.85% to 15,557.69. The S&P 500 also rose, gaining, 0.53% to 4,890.27.

ANVS

1 minute read

M&A
News

SciSparc Entered, As Lender, Into A Bridge Loan Agreement With Vehicle Importer Company In Israel; Target Company Received $1.4M Bridge Loan Further To The Previously-Announced Non-Binding Letter Of Intent For Company To Acquire The Target Company

By Benzinga Newsdesk

January 19, 10:32 AM

As previously announced on December 7, 2023, the Company intends to acquire 100% of the Target Company and will establish a new wholly-owned Israeli subsidiary, which would in turn merge with and into the Target Company.

SPRC

3 minute read

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Avi Kapoor

December 13, 2:40 PM

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.

ABM

1 minute read

Movers
News

What’s Going On With SciSparc Ltd Stock?

By Erica Kollmann

December 13, 12:58 PM

SciSparc Ltd. (NASDAQ: SPRC) shares are trading higher Wednesday.

SPRC

2 minute read

SciSparc Announces Results For MitoCareX Bio With Its Drug Discovery Platform; MitoCareX Bio Met Its Second Milestone As Part Of Its Joint Venture Agreement With The Company

By Benzinga Newsdesk

December 13, 9:20 AM

MitoCareX Bio met its second milestone as part of its joint venture agreement with the CompanyTEL AVIV, Israel, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty

SPRC

4 minute read

Psyched: Defense Dept.’s Ketamine Trial, Cybin’s Psilocybin, Metabolic Disorders, Reform Update And More

By Lara Goldstein

December 5, 11:12 AM

Defense Dept. Funds Ketamine Study For PTSD Treatment

ATAI

2 minute read

Weight Loss Treatment: The Collaboration Between Scisparc And Clearmind Continues To Yield Results In Its Obesity And Metabolic Disorder Program

By Benzinga Newsdesk

December 1, 9:16 AM

The collaboration between SciSparc and Clearmind continues to yield positive results in its obesity and metabolic disorder programTEL AVIV, Israel, Dec. 01, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company"

CMND

2 minute read

SciSparc Adopts Limited Duration Shareholder Rights Plan

By Benzinga Newsdesk

November 28, 10:06 AM

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system,

SPRC